# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Tuniu sees significant revenue growth in Q4 2023, driven by packaged tours, and initiates a $10 million share repurchase program.
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...
Share Repurchase Program In March 2024, the Company's Board of Directors authorized a share repurchase program under which...
Business Outlook For the first quarter of 2024, Tuniu expects to generate RMB101.1 million to RMB107.4 million of net revenues...
Tuniu (NASDAQ:TOUR) reported quarterly losses of $(0.15) per share. The company reported $14.08 million in sales this quarter....
Pursuant to the Nasdaq Listing Rules 5810(c)(3)(A), the Company is provided with a compliance period of 180 calendar days, or u...